privat held neorx corp said has enter into exclus agreement with genentech inc for develop inject diagnost imag blood clot said genentech will respons for market and neorx will receiv royalti base sale product will proprietari neorx method attach radioisotop technetium 99m genentech blood clot dissolv drug tissu plasminogen activ activas reuter 